- Home
- PNI vs FORA Comparison
PNI vs FORA Comparison
Compare PNI & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNI
- FORA
- Stock Information
- Founded
- PNI 2002
- FORA 2014
- Country
- PNI United States
- FORA United States
- Employees
- PNI N/A
- FORA N/A
- Industry
- PNI Trusts Except Educational Religious and Charitable
- FORA Computer Software: Prepackaged Software
- Sector
- PNI Finance
- FORA Technology
- Exchange
- PNI Nasdaq
- FORA Nasdaq
- Market Cap
- PNI 75.2M
- FORA 66.1M
- IPO Year
- PNI N/A
- FORA N/A
- Fundamental
- Price
- PNI $6.76
- FORA $1.96
- Analyst Decision
- PNI
- FORA Strong Buy
- Analyst Count
- PNI 0
- FORA 1
- Target Price
- PNI N/A
- FORA $5.00
- AVG Volume (30 Days)
- PNI 26.4K
- FORA 8.1K
- Earning Date
- PNI 01-01-0001
- FORA 08-13-2025
- Dividend Yield
- PNI 4.76%
- FORA N/A
- EPS Growth
- PNI N/A
- FORA N/A
- EPS
- PNI N/A
- FORA N/A
- Revenue
- PNI N/A
- FORA $22,332,001.00
- Revenue This Year
- PNI N/A
- FORA $13.31
- Revenue Next Year
- PNI N/A
- FORA $43.65
- P/E Ratio
- PNI N/A
- FORA N/A
- Revenue Growth
- PNI N/A
- FORA 5.22
- 52 Week Low
- PNI $6.03
- FORA $1.85
- 52 Week High
- PNI $7.89
- FORA $4.03
- Technical
- Relative Strength Index (RSI)
- PNI 56.47
- FORA 43.34
- Support Level
- PNI $6.61
- FORA $1.95
- Resistance Level
- PNI $6.77
- FORA $2.09
- Average True Range (ATR)
- PNI 0.06
- FORA 0.10
- MACD
- PNI 0.01
- FORA -0.02
- Stochastic Oscillator
- PNI 93.75
- FORA 3.33
About PNI Pimco New York Municipal Income Fund II of Beneficial Interest
PIMCO New York Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State and New York City income tax. The fund portfolio of investments consists of investments in different sectors such as education, transportation, healthcare, and others.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.